| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-27 | FY 2024
FILED 2024-09-28 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $4.03B | $3.96B | $4.21B |
| YoY Revenue Growth % | +1.8% | -5.9% | — |
| Gross Profit | $406.5M | $378.5M | — |
| Gross Margin % | 10.1% | 9.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $202.4M | $167.7M | $195.8M |
| Operating Margin % | 5.0% | 4.2% | 4.7% |
| Net Income (GAAP) | $172.9M | $111.8M | $139.1M |
| EBITDA (Normalized) | $278.6M | $243.9M | $347.4M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $249.2M | $436.5M | $165.8M |
| Capital Expenditures (CapEx) | $95.3M | $95.2M | $189.5M |
| Free Cash Flow (FCF) | $154.0M | $341.3M | -$23.6M |
| FCF Margin % | 3.8% | 8.6% | -0.6% |
| Return on Invested Capital (ROIC %) | 8.0% | 7.4% | 5.1% |
| Cash & Short-Term Equivalents | $248.8M | $317.2M | — |
| Total Debt (Short + Long Term) | $767.2M | $788.5M | $1.18B |
| Total Stockholders' Equity | $1.48B | $1.32B | $2.43B |